Early research suggests promise

Early research suggests promise

by | Jan 5, 2022 | Floral Releaf News | 0 comments



What the Study says

OSU’s Van Breemen stated that CBDA and CBGA blocked the action of emerging variants of the virus that causes Covid-19, saying that “our research showed the hemp compounds were equally effective against variants of SARS-CoV-2, including variant B.1.1.7, which was first detected in the United Kingdom, and variant B.1.351, first detected in South Africa.” This could be a game-changer for the COVID-19 pandemic. The study found that it is ideal ingest the compounds and stated that, “Smoking cannabis does not offer any protection.”

Here is the Oregon State University study

We Sell a Full Line of phytocannabinoid Supplements

Floral Releaf offers a full selection of Softgels that support Anti-Inflammatory (15mg CBDA), Antioxidant Immunity (15mg CBD isolate and 25mg CBG Full Spectrum), and Rest Well (10mg CBN and 15mg CBG Full Spectrum). 

 Click here to shop for all of our Softgels


Submit a Comment